Elekta treats patients of both the present and the future
Since it was established in Australia in 2004 as a direct subsidiary of its corporate headquarters in Sweden, Elekta Australasia has served the radiation oncology, medical oncology and neuroscience communities throughout Australia and New Zealand with world-class clinical solutions and services.
The company has worked with several prestigious hospitals in Australia, including the Princess Alexandra Hospital in Brisbane. Among Elekta’s missions are maintaining customer satisfaction
Click here to read the latest edition of Business Review Australia!
“Our prime focus is establishing high customer satisfaction and meeting customer expectations, and expectations are high in Australia,” said Managing Director Shaun Seery.
Technology and Innovations
Elekta pioneered the 4D CT technique, an imaging workflow that enables doctors to acquire images of moving targets in the body. Accordingly, 4D CT is particularly useful for treating lung cancer, in which tumors can change position with patient breathing.
Another innovation is the 160-leaf multileaf collimator (MLC), Agility™, a beam-shaping device that is the fastest in the industry. Combined with a High Dose Rate mode, clinicians can use the linear accelerator to treat patients faster and with greater therapeutic effect.
RELATED TOPIC: 4WEB Medical brings 3D printing implants to Australia
“If you can be more confident where you’re going to deliver the dose, you can deliver a higher dose to the tumor,” said Seery. “With that you’ll be able to hypofractionate for some indications, which would reduce the number of treatments the patient will have to come for.”
According to Seery, the best practice is eliminating the number of required treatments. Instead of having 30-35 treatments, the goal is to bring it down to 10-15.
The company prides itself on updating its technology and innovations… click here to read the rest of this article on Business Review Australia!